18
Participants
Start Date
April 30, 2021
Primary Completion Date
October 9, 2023
Study Completion Date
October 9, 2023
MM09-MG01(30.000-30.000)
Mite mixture (Dermatophagoides pteronyssinus and Dermatophagoides farinae) with a concentration of 30,000 AU / mL and grasses mixture (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca elatior, Lolium perenne and Dactylis glomerata) with a concentration of 30,000 AU / mL: Purified allergenic extract, adsorbed in aluminum hydroxide and polymerized with glutaraldehyde
MG01(30.000)
Grasses mixture (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca elatior, Lolium perenne and Dactylis glomerata) with a concentration of 30,000 AU / mL: Purified allergenic extract, adsorbed in aluminum hydroxide and polymerized with glutaraldehyde
MM09(30.000)
Mite mixture (Dermatophagoides pteronyssinus and Dermatophagoides farinae) with a concentration of 30,000 AU / mL: Purified allergenic extract, adsorbed in aluminum hydroxide and polymerized with glutaraldehyde
Placebo subcutaneous
The same solution, presentation, method of administration, frequency, and duration as the active treatment, but without active ingredients.
Centro Médico ASISA Dr. Lobatón, Cadiz
Hospital Santa Bárbara, Puertollano
Hospital Universitario A Coruña, A Coruña
C.P.E. Virgen de la Cinta - Hospital Universitario Juan Ramón Jiménez, Huelva
Hospital el Bierzo, Ponferrada
Hospital Universitario Lucus Augusti, Lugo
Hospital Quirón Salud Málaga, Málaga
Hospital Regional Universitario de Málaga, Málaga
Hospital Universitario de Navarra, Pamplona
Hospital Universitario Virgen Macarena, Seville
Hospital Clínico Universitario de Valencia, Valencia
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat
Hospital Universitario de Álava, Vitoria-Gasteiz
Lead Sponsor
BioClever 2005 S.L.
OTHER
NTS hub S.L
UNKNOWN
Inmunotek S.L.
INDUSTRY